- Usio, Inc. (USIO) Stock Rising +19.13% After Signing A Non-binding LOI To Purchase IMS
- Chevron Corp (CVX) Reports Profit of $201 million in third quarter 2020
- IBM Enters Esports Arena with Activision Blizzard in New Multi-Year Deal as the Presenting Partner of the Overwatch League Grand Finals
- U.S. General Services Administration (GSA) Deploys BIO-key’s PortalGuard Identity and Access Management (IAM) Solution for Two-factor Authentication Compliance
- J Jill Declares Transaction Support Agreement (TSA) to consolidate its Balance Sheet and Position the Company for Long-Term Growth
SUI Feasibility research in Viveve Medical, Inc. (NASDAQ:VIVE) showed Positive efficacy data and Preclinical outcomes that favor the Viveve’s New Sham Tip for Critical PURSUIT Trial
Viveve Medical, Inc. (NASDAQ:VIVE), is a medical technology company whose research area is women’s intimate health. The company has recently reported that its three arm feasibility study on five month Stress Urinary Incontinence (SUI), which was based on comparing the Viveve’s Cryogen-cooled Monopolar Radiofrequency (CMRF) treatment and a cryogen-only sham treatment to an inert sham treatment to restrain SUI in women ,has showed primarily positive data. Moreover the company also announced positive results from an…
Read More